NSE - SMEListed
Saroja Pharma Industries India Limited
Company websiteSaroja Pharma Industries India Limited plans to raise ₹10,84,800 crore via IPO. That includes a fresh infusion of ₹10,84,800 crore and an OFS worth ₹0 crore.
Apply from 31-08-2023 until 05-09-2023. Allotment and tentative listing are scheduled for 12-09-2023 and 13-09-2023. Quick tip: check lot size and valuation before bidding.
Start Date31-08-2023
End Date05-09-2023
Listing Date13-09-2023
Allotment Date12-09-2023
Current Price₹65
GMP₹0 (0.00%)
Lot Size1600 Shares
Subscription8.86 Times
Face Value₹10 per share
Listing atNSE
Issue Price₹84 - ₹84
Pre Issue₹29,35,686
Post Issue₹40,20,486
Issue Size₹10,84,800
(aggregating up to 9.11 Cr)
(aggregating up to 9.11 Cr)
Fresh Issue₹10,84,800
(aggregating up to 9.11 Cr)
(aggregating up to 9.11 Cr)
Offer For Sale-
The Grey Market Premium (GMP) for Saroja Pharma Industries India Limited is currently around ₹0 (0.00%). This indicates an estimated listing price of approximately ₹84 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
07 Nov 2025, 08:21 | ₹84 | ₹0 | ₹84 (0.00%) |
19 Mar 2025, 11:25 | ₹84 | ₹0 | ₹84 (0.00%) |
Financials overview In Lakhs
Here is a quick look at the recent financial performance of Saroja Pharma Industries India Limited . The numbers below ( In Lakhs ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
Key Performance
| KPI | Values |
|---|---|
EPS | 3.61 |
ROE | 0.15 |
ROCE | 0.25 |
RONW | 20.85 |
PRE IPO(PE) | 23.27 |
POST IPO(PE) | 31.82 |
Subscription Demand (in ₹ Crore)
| Category | Offered | Demand | Times |
|---|---|---|---|
RETAIL | ₹4.33 | 63.8 | 14.73 |
Total | ₹4.33 | 63.80 | 14.73 |
The IPO reservation for Saroja Pharma Industries India Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
Retail | 47.49% | 5,15,200 |
NII(HNI) | 47.49% | 5,15,200 |
Market Maker | 5.01% | 54,400 |
TOTAL | 100.00% | 10,84,800 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail (Min) | 1 | 1,600 | ₹1,34,400 | |
HNI | 2 | 3,200 | ₹2,68,800 |
Below you can find the official contact details of Saroja Pharma Industries India Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Email: info@sarojapharma.com
Phone: +91 (022) 2081 0011
Website: https://www.sarojapharma.com/
Address: 305, Kailash Tower, Shiv Shristi Complex, Goregaon Link Road, Mulund West, Mumbai (MH) – 400080